Meningococcal Surveillance Australia: Reporting period 1 July to 30 September 2021

Authors

  • Monica M Lahra World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory. NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Kensington, NSW, 2052, Australia.
  • Masoud Shoushtari World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory. NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW, 2031, Australia
  • Tiffany R Hogan
  • National Neisseria Network, Australia

DOI:

https://doi.org/10.33321/cdi.2022.46.1

Keywords:

antimicrobial resistance, disease surveillance, meningococcal disease, Neisseria meningitidis

Abstract

The Australian National Neisseria Network (NNN) comprises reference laboratories in each state and territory that report data on antimicrobial susceptibility testing to an agreed group of antimicrobial agents for the Australian Meningococcal Surveillance Programme (AMSP). This report presents national meningococcal antimicrobial resistance surveillance data for the indicated quarter.

Downloads

Download data is not yet available.

Downloads

Published

27/01/22

How to Cite

Lahra, Monica M, Masoud Shoushtari, Tiffany R Hogan, and National Neisseria Network, Australia. 2022. “Meningococcal Surveillance Australia: Reporting Period 1 July to 30 September 2021”. Communicable Diseases Intelligence 46 (January). https://doi.org/10.33321/cdi.2022.46.1.

Issue

Vol. 46 (2022)

Section

Quarterly report

Categories

License

Copyright (c) 2022 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>